By Brazil Stock Guide – Brazilian health insurer Amil has ended negotiations with Bain Capital and Advent International over a potential investment in the company, after differences over the structure of the partnership and the investors’ role in the business prevented an agreement.
Bain and Advent had joined forces in the talks, but were seeking a larger role in Amil’s decision-making structure than José Seripieri Junior, the company’s owner and chairman, was prepared to grant.
Seripieri was looking for a partner with whom he could share Amil’s next phase of growth while preserving a central role in strategic decisions. With the two sides unable to bridge their differences over that balance, the decision was made not to proceed with the transaction.
An outright sale of Amil was also considered during the process.
The company’s improving operating performance also changed the dynamics of the negotiations. Amil has around 3.5 million members and expects to close the year with EBITDA of about R$2.5 billion, reducing the pressure to complete a transaction quickly.
With the business in a stronger financial position, Seripieri gained greater flexibility to consider a potential partnership without time pressure and without having to accept a structure he viewed as inappropriate for Amil’s future.
In a statement sent to employees on Thursday, September 10, Amil’s board confirmed that the negotiations had ended and said the process concluded “without any change to the company’s ownership structure.”
The company said it had received proposals ranging from the acquisition of a stake to a purchase of 100% of Amil. The statement did not identify Bain or Advent and provided no details about the terms discussed during the process.
Amil, however, made clear that the decision does not permanently close the door to new investors. The company said it would remain open to proposals for minority investments, provided they preserve the group’s principles and values.
The outcome marks an important shift in Amil’s position. After roughly two and a half years of recovery, the discussion is no longer primarily about the need to bring in an investor, but rather about which partner could add value to the company’s next phase without upsetting the balance of control Seripieri wants to preserve.
In practice, Seripieri tested investor appetite, assessed the proposals on the table and ultimately chose to preserve strategic flexibility as Amil’s performance improved. A new shareholder could still come in, but without the sense of urgency that had characterized the negotiations over the past six months.
Leave a Reply